PsyBio Therapeutics Corp.
TSXV: PSYB.V0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Toronto Stock Exchange Ventures
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Evan Mike Levine
- Employees
- 4
- Headquarters
- Coconut Creek, United States
- IPO year
- 2021
- Market cap
- CA$956.5K
- Website
- https://www.psybiolife.com
Loading PSYB…
Loading profile data…Frequently asked questions about PSYB
What does PsyBio Therapeutics Corp. (PSYB.V) do?
PsyBio Therapeutics Corp., a biotechnology company, focuses on the research, development, and commercialization of psychedelic-inspired regulated medicines for the treatment of mental health and other disorders in the United States. The company is headquartered in Coconut Creek, Florida.
Where does PSYB.V trade?
PsyBio Therapeutics Corp. (PSYB.V) trades on the Toronto Stock Exchange Ventures.
What sector is PSYB.V in?
PsyBio Therapeutics Corp. (PSYB.V) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of PsyBio Therapeutics Corp.?
Evan Mike Levine is the chief executive officer of PsyBio Therapeutics Corp. (PSYB.V).
Where is PsyBio Therapeutics Corp. headquartered?
PsyBio Therapeutics Corp. is headquartered in United States.
Does PSYB.V pay a dividend?
PsyBio Therapeutics Corp. (PSYB.V) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did PSYB.V go public?
PsyBio Therapeutics Corp. (PSYB.V) completed its initial public offering in 2021.